semaglutide
Butler holds firm on semaglutide compounding ban
Government says ‘no’, to lifting ban on compounding glucagon-like peptide-1 receptor agonists (GLP-1 RAs) Risks associated with compounded GLP-1 RAs outweigh the benefits of improved access to the medication, Mark …
Confusion with Wegovy prescriptions
PDL offers advice for pharmacists regarding Wegovy (semaglutide) following a number of incident reports Pharmacists are likely aware that Wegovy (semaglutide) is now available in Australia. The PDL Professional Officers …
Wegovy’s arrival provides Ozempic alternative for weight management
Supplies of Ozempic (semaglutide) should be prioritised for type 2 diabetes patients the TGA says, as sponsor Novo Nordisk, launches its Wegovy brand for weight loss Pharmacists and prescribers are …
Ozempic shortages to continue: Butler
Novo Nordisk “simply doesn’t have the factories” to meet growing demand for Ozempic, Health Minister says Shortages of Novo Nordisk’s diabetes medication, Ozempic (semaglutide) are likely to continue into 2025, …
Inquiry backs expansion of GLP-1 RA eligibility
Government urged to make Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) available to more patients Steps to improve access to GLP-1 RAs for high-risk patients are among 23 recommendations in the …
WHO issues global warning on fake GLP-1 RAs
WHO Global Surveillance and Monitoring System observes increasing reports of “falsified semaglutide products in all geographic regions” The World Health Organization (WHO) has issued a medical product alert related to …
Ozempic compounding ban no ‘knee-jerk’ reaction
Department defends recommendation to ban the compounding of semaglutide and tirepatide medications Moves to prohibit pharmacists from compounding replicas of Ozempic (semaglutide) and Mounjaro (tirepatide) were not a “knee-jerk response” …
TGA urges caution over unsolicited compounding offers
GPs are being advised to “exercise deep caution” when contacted with offers to provide compounded semaglutide Prescribers are being warned by the Therapeutic Goods Administration (TGA) not to be “duped” …
‘Like every service they must be used safely’
The TGA is looking at cracking down on the compounding of injectable weight loss medicines, following the concerns it expressed last year The Therapeutic Goods Administration has announced that it …
Ozempic scam threatens compounder’s reputation
Compounding pharmacist fears his business could be damaged by scammers offering to compound semaglutide, using a similar name to his pharmacy Sydney-based compounder, Adam Reinhard, believes the reputation of The …
TGA flags compounded Ozempic safety concerns
Pharmacists are being warned that they could be liable for any adverse outcome patients experience should they supply compounded semaglutide-like products Reports that a telehealth provider plans to make compounded …
Novo goes after pharmacies compounding semaglutide
Danish pharma giant declares some compounded versions up to one-third impure The manufacturer of diabetes and weight-loss drugs Ozempic and Wegovy has taken legal action against two compounding pharmacies, accusing …